Propanc Biopharma, Inc. Common Stock

PPCB XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

Short interest (May 15)

2.8%

Net Short (Jun 03 ): -0.1%

Borrow Fee

10.92%

↓ 3.5%

Available Shares

30K

↓ 91.7%

Price Chart

Company Overview

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001517681

Asset Type: CS

Market Data

Market Cap: $4,032,716

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 10.92%

Range: 10.92% - 11.25%

Available Shares 30K

Range: 10K - 25K

Recent Changes

Fee Change: ↓ 6.5%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime